Bimatoprost Powder CAS 155206-00-1 Bimatoprost Raw Material Bimatoprost Powder Purity Bimatoprost

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 155206-00-1
• Keyword: Bimatoprost
• Keyword 1: Bimatoprost Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Product Description

Description

Bimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin.    Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form.    It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma.    Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth.   It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.
Bimatoprost is a medicine that treats high pressure in the eye (ocular hypertension) and helps with glaucoma.   High pressure can happen when too much fluid builds up inside your eye.    Bimatoprost helps to drain the fluid.   If not treated,high pressure can damage your optic nerve and cause vision loss or blindness.   Bimatoprost is available on prescription only

Product name	Bimatoprost
Appearance	white Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

Bimatoprost is used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
These patients must be intolerant to other intraocular pressure lowering medications or inadequately responsive to other treatments.
Bimatoprost has a rejuvenating effects on the hair follicles.   This was first noticed when the eye drops caused a lengthening and thickening of the eyelashes.   According to one official study, "bimatoprost offers a novel, and apparently low-risk, approach for treating scalp alopecias".   Although the exact mechanism at work is not yet understood, it is clear that the topical form stimulates the hair follicles to produce healthy hairs.